QIAGEN N.V. (QGEN) vs Sotera Health Company (SHC)
QIAGEN N.V. and Sotera Health Company are both Diagnostics & Research companies. QIAGEN N.V. is the larger, with a market value of $9.3B against $5.3B — 1.8× the size. QIAGEN N.V. trades at the lower P/E: 22.6× against 32.1×. Sotera Health Company grew revenue faster over the last twelve months: 8.15% against 2.96%. QIAGEN N.V. has the higher net margin (19.5% vs 13.4%) and the lower return on invested capital (6.62% vs 9.82%). Across the 22 metrics below, QIAGEN N.V. leads on 15 and Sotera Health Company on 7.
Valuation
Profitability
| Metric | QGEN | SHC | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 62.20% | 54.97% | 50.89% |
| Operating margin | 21.21% | 32.82% | (8.57%) |
| Net margin | 19.49% | 13.44% | (6.37%) |
| Free cash flow margin | 20.98% | 9.27% | 0.00% |
| Return on equity | 11.93% | 27.78% | (2.92%) |
| Return on assets | 6.99% | 5.01% | (6.71%) |
| Return on invested capital | 6.62% | 9.82% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack